Rodo Medical and Straumann Group enter distribution agreement; Straumann increases investment

Rodo Medical and Straumann Group announced that Straumann increased its stake in Rodo Medical from 12% to 30% and obtained exclusive distribution rights for Rodo's Smileloc dental implant retention devices outside North America and South Korea, with an option to increase to 51% in 2021.

“RODO's ability to develop a revolutionary concept, turn it into a medical device and bring it to market is impressive.”prnewswire.com

• 1 source
• prnewswire.comRodo Medical and Straumann Group enter into Distribution Agreement Outside North America; Straumann Increases Its Investment in Rodo MedicalRodo Medical, Inc.Apr 28, 2017

Summarized from public sources; check the original articles before acting on it.